SB-423562 is a short-acting calcium-sensing receptor (CaR) antagonist.
[1]. Kumar S, et al. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone. 2010 Feb;46(2):534-42.
















